Ceribell produces the world's first brain monitor designed for point-of-care seizure triage and treatment. Their technology allows healthcare providers to quickly test for seizures and administer treatments within minutes, significantly improving patient outcomes. As a rapidly growing medical technology startup backed by venture capital, Ceribell's innovations are deployed in hundreds of community hospitals and large academic facilities across the United States. With rigorous clinical validation of their products and a solid growth trajectory leading up to a potential IPO, Ceribell offers a dynamic environment for professionals looking to make a tangible impact in the healthcare industry. The company encourages a mission-driven culture and values collaboration and excellence among its team.